Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.
Hwang WL, Chen TC, Lin HY, Chang MC, Hsiao PC, Bai LY, Kuo CY, Chen YC, Liu TC, Gau JP, Wang PN, Hwang WS, Kuo MC, Liu CY, Liu YC, Ma MC, Su NW, Wang CC, Wu YY, Yao M, Yeh SP, Cheng HW, Lee YM, Ku FC, Tang JL. Hwang WL, et al. Among authors: su nw. Int J Hematol. 2022 May;115(5):704-712. doi: 10.1007/s12185-022-03311-1. Epub 2022 Feb 25. Int J Hematol. 2022. PMID: 35212915
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population.
Chiang YH, Chang YC, Lin HC, Huang L, Cheng CC, Wang WT, Cheng HI, Su NW, Chen CG, Lin J, Chang YF, Chang MC, Hsieh RK, Chou WC, Lim KH, Kuo YY. Chiang YH, et al. Among authors: su nw. Oncotarget. 2017 Jul 12;8(44):76204-76213. doi: 10.18632/oncotarget.19211. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100304 Free PMC article.
Bilateral xanthogranulomatous pyelonephritis.
Tsai KH, Lai MY, Shen SH, Yang AH, Su NW, Ng YY. Tsai KH, et al. Among authors: su nw. J Chin Med Assoc. 2008 Jun;71(6):310-4. doi: 10.1016/S1726-4901(08)70128-X. J Chin Med Assoc. 2008. PMID: 18567562 Free article. Review.
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.
Cheng CC, Chou KF, Wu CW, Su NW, Peng CL, Su YW, Chang J, Ho AS, Lin HC, Chen CG, Yang BL, Chang YC, Chiang YW, Lim KH, Chang YF. Cheng CC, et al. Among authors: su yw, su nw. Lung Cancer. 2018 Feb;116:80-89. doi: 10.1016/j.lungcan.2017.12.017. Epub 2017 Dec 29. Lung Cancer. 2018. PMID: 29413056
55 results